"When innovation outpaces regulation pharma leaders must cross organisational boundaries" - Nick Petschek, EMEA MD at Kotter.
Stories have continued to emerge surrounding the surge of counterfeit versions of Eli Lilly’s weight-loss drug Retatrutide being sold on TikTok and Meta platforms, posing a dangerous challenge for the pharmaceutical industry. With copies of unlicensed and unproven weight-loss drugs circulating online, pharmaceutical leaders not only face the responsibility of safeguarding public health and protecting their brand’s integrity, but preserving trust in innovation when regulatory timelines can’t keep up with digital demand.